Study identifier:D133HR00026
ClinicalTrials.gov identifier:NCT05887011
EudraCT identifier:N/A
CTIS identifier:N/A
National multicentre non-interventional study to assess CRT patterns and short-term outcomes on unresectable NSCLC and SCLC in routine practices in Russia
unresectable /inoperable locally advanced (stage II-III) NSCLC and locally advanced LS-SCLC (stage I-III)
N/A
No
-
All
2000
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Apr 2025 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
LA NSCLC unresectable/inoperable (stage II-III) locally advanced Non-Small Cell Lung Cancer | - |
LS-SCLC unresectable/inoperable Limited-stage small cell lung carcinoma (stage I-III) | - |